Dr Roberto Liddi

Dr. Roberto Liddi has extensive work experience in the fields of regulatory compliance and quality assurance. Dr Roberto is currently the Vice President Regulatory & Compliance at NuraLogix Corporation since June 2023. Before that, they worked as the Vice President at SWORD Health from May 2022 to June 2023. Prior to these roles, Dr. Liddi held various positions at Sensyne Health, including Chief Regulatory Quality & IG Officer from May 2021 to May 2022, Senior Vice President Quality Regulatory & IG from December 2019 to April 2021, and Vice President Quality and Regulatory from an unspecified date in 2018 to December 2019. Additionally, they served as the Corporate Director QARA at STS Medical Group from January 2018 to May 2018. Earlier in their career, Dr. Liddi worked as the Head of Corporate QARA Medical Divisions at Renishaw plc from May 2013 to December 2017, as well as the Senior Director Regulatory Affairs and Regulatory Compliance EMEA at KCI Europe Holdings and KCI from April 2009 to May 2013. Dr Roberto also held the position of Associate Director at Zimmer from April 2007 to March 2009 and Head of QA at Cozart plc from March 2001 to August 2005. Dr Roberto began their career as a Lecturer at UCLH, Middlesex Hospital from March 2000 to March 2001.

Dr Roberto Liddi obtained their Doctor in Biological Sciences from Università degli Studi di Bari from 1986 to 1991, specializing in Human Biology. Dr Roberto then pursued a Master's degree in Immunology at Politecnico di Bari from 1991 to 1993. No information is available regarding their education at Di Cagno Abbrescia Bari. Dr Liddi also holds a certification in MTOPRA from TOPRA, although the specific details of when and where they obtained this certification are not provided.